Docoh
Loading...

GTH Genetron

Genetron Holdings Limited ("Genetron Health" or the "Company") is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive oncology portfolio that covers the entire spectrum of cancer management, addressing needs and challenges from early screening, diagnosis and treatment recommendations, as well as continuous disease monitoring and care. Genetron Health also partners with global biopharmaceutical companies and offers customized services and products.

GTH stock data

(
)

Calendar

9 Apr 21
19 Oct 21
31 Dec 21
Quarter (USD)
Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Genetron earnings reports.

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 51 48 +6.3%
Opened positions 9 44 -79.5%
Closed positions 6 0 NEW
Increased positions 12 0 NEW
Reduced positions 17 0 NEW
13F shares
Current Prev Q Change
Total value 7.38B 7.61B -3.0%
Total shares 179.78M 180.01M -0.1%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Wang Sizhen 79.07M $1.11B 0.0%
Tianjin Genetron Jun'an Business Management Partnership 30.15M $422.13M 0.0%
Vivo Capital IX 28.57M $410.33M 0.0%
Wealth Strategy 23.4M $327.62M 0.0%
Vivo Capital 6.34M $127.69M 0.0%
Capital World Investors 2.47M $49.79M 0.0%
Jennison Associates 2.13M $42.85M +6.7%
RTW Investments 1.82M $36.62M 0.0%
BLK Blackrock 1.12M $22.49M +3.4%
Platinum Investment Management 814.67K $16.41M +16.9%
Largest transactions
Shares Bought/sold Change
Yong Rong 0 -257.49K EXIT
Marshall Wace 15.18K -188.78K -92.6%
Cormorant Asset Management 132.87K -167.13K -55.7%
Jennison Associates 2.13M +133.69K +6.7%
Platinum Investment Management 814.67K +117.66K +16.9%
HBCYF HSBC 0 -115.11K EXIT
Driehaus Capital Management 238.16K +92.16K +63.1%
BLVGF Bellevue 723.14K +91.05K +14.4%
GS Goldman Sachs 82.98K +82.98K NEW
Renaissance Technologies 79.6K +79.6K NEW
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. sophomore Avg

Proxies

No filings